LIPOCINE INC. Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve
LIPOCINE INC. (LPCN) reported Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve · last filed 2020-03-13
- LIPOCINE INC. increase (decrease) in liability for claims and claims adjustment expense reserve for the quarter ending 2018-12-31 was $0.00, a 100.00% decline year-over-year.
- LIPOCINE INC. increase (decrease) in liability for claims and claims adjustment expense reserve for the quarter ending 2018-09-30 was $0.00.
- LIPOCINE INC. increase (decrease) in liability for claims and claims adjustment expense reserve for the quarter ending 2017-12-31 was $4.25M.
- LIPOCINE INC. increase (decrease) in liability for claims and claims adjustment expense reserve for the quarter ending 2017-09-30 was $0.00.
- LIPOCINE INC. increase (decrease) in liability for claims and claims adjustment expense reserve for fiscal 2019 was $0.00.
- LIPOCINE INC. increase (decrease) in liability for claims and claims adjustment expense reserve for fiscal 2018 was -$4.25M, a 200.00% decline from fiscal 2017.
- LIPOCINE INC. increase (decrease) in liability for claims and claims adjustment expense reserve for fiscal 2017 was $4.25M.
- LIPOCINE INC. increase (decrease) in liability for claims and claims adjustment expense reserve for fiscal 2016 was $0.00.
| Period end | Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve 3 month | Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve 6 month | Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve 9 month | Increase (Decrease) in Liability for Claims and Claims Adjustment Expense Reserve 12 month |
|---|---|---|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-13 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | -$4.25M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$4.25M 10-Q · filed 2018-11-07 | ||
| 2018-06-30 | -$4.25M 10-Q · filed 2018-08-07 | |||
| 2017-12-31 | $4.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $4.25M derived: sum of 2 quarters · filed 2019-03-06 | $4.25M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-07 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-03-06 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |